North America vs Singapore: Survival to age 65, female
North America
88.9%
in 2024
Singapore
94.6%
in 2024
North America rank
9th
Singapore rank
12th
Survival to age 65, female over time
- North America
- Singapore
How they compare
Singapore currently reports 94.6% against 88.9% in North America, a difference of 5.7%.
That makes Singapore's figure about 1.1 times North America's.
The two have swapped places 1 time across 65 shared years of data; in 1960 it was North America ahead.
North America ranks 9th and Singapore ranks 12th of 47 groups.
Across the 7 decades both report, North America averaged higher in 3 and Singapore in 4.
Head to head by decade
| Decade | North America | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 1960s | 79.1% | 73.7% | 5.4% | North America |
| 1970s | 81.8% | 78.7% | 3.1% | North America |
| 1980s | 84.5% | 82.5% | 2.0% | North America |
| 1990s | 86.1% | 86.8% | 0.7% | Singapore |
| 2000s | 87.4% | 91.0% | 3.6% | Singapore |
| 2010s | 88.2% | 93.5% | 5.2% | Singapore |
| 2020s | 87.3% | 93.9% | 6.6% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher survival to age 65, female, North America or Singapore?
- Singapore, at 94.6% against 88.9% in North America as of 2024.
- What is the difference in survival to age 65, female between North America and Singapore?
- 5.7%, with Singapore ahead.
- How many years of comparable data are there for North America and Singapore?
- 65 years are reported by both, from 1960 to 2024.
- How do North America and Singapore rank globally for survival to age 65, female?
- North America ranks 9th and Singapore ranks 12th of 47 groups.
- Where does this data come from?
- World Population Prospects, United Nations (UN), publisher: UN Population Division, published as Survival to age 65, female (% of cohort). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Survival to age 65 refers to the percentage of a cohort of newborn infants that would survive to age 65, if subject to age specific mortality rates of the specified year.